Price T Rowe Associates Inc Prometheus Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$103.46 - $126.29 $44.5 Million - $54.3 Million	430,273 Added 94.55%	885,332 $95 Million
Q4 2022 Feb 14, 2023	BUY	$36.06 - $117.21 $13 Million - $42.2 Million	359,970 Added 378.56%	455,059 $50.1 Million
Q3 2022 Nov 14, 2022	BUY	$28.17 - $59.01 $2.68 Million - $5.61 Million	95,089 New	95,089 $5.61 Million
Q2 2021 Aug 16, 2021	SELL	$16.8 - $29.65 $8.82 Million - $15.6 Million	-525,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$16.51 - $25.29 $8.67 Million - $13.3 Million	525,000 New	525,000 $9.59 Million

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.